ArticleInvestigative ophthalmology & visual science2026
Nephronectin Promotes Migration of the Periocular Mesenchyme via EGFR Signaling.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Purpose: Nephronectin (Npnt) is an extracellular protein with various functions during development and homeostasis of various tissues, but its role during early mouse cornea development remains unexplored. We characterized the expression of Npnt and investigated its function during cornea development. Methods: We performed in situ hybridization and immunohistochemistry on ocular sections obtained from embryonic day (E)11.5-E16.5 mouse embryos. Wild-type and Npnt mutant embryos were analyzed for corneal thickness, cell number, and cell proliferation. We assessed the expression of Npnt receptors, Integrin alpha 8 (Itgα8) and Epidermal growth factor receptor (EGFR). We performed in vitro migration assays using periocular mesenchyme (POM) explants in the presence of EGFR and STAT3 inhibitors. Results: Npnt mRNA was expressed in the ectoderm, lens, optic cup, and subsequently in the cornea endothelium. Npnt protein correlated with mRNA staining with additional localization in the epithelial basement membrane and POM. Npnt mutants exhibited reduced corneal thickness and cell numbers compared to wild-type littermates, but there were no differences in cell proliferation. Itgα8 mRNA was diffusely expressed in the POM, but not in the migratory regions. EGFR mRNA was expressed in the region of migratory POM. Robust cell migration occurred from POM explants cultured on either Npnt or Fibronectin (Fn) substrates, but the EGFR pathway inhibitors only attenuated migration on the Npnt substrate. Conclusions: Npnt is expressed in the periocular region during ocular development and contributes to POM migration into the nascent cornea via a mechanism that involves activation of the EGFR signaling pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.